Event JSON
{
"id": "c7ea091b901465f63b081872add9d7c9e6b9740ea949690ebbfb111dda18735d",
"pubkey": "dd19d183e3f1a03d4a5119625c50db540b028ae0a098c96e4c5316df3ef5a11d",
"created_at": 1732207159,
"kind": 1,
"tags": [
[
"r",
"https://www.salon.com/2024/11/21/novo-nordisks-wegovy-launches-in-china-offering-obesity-at-a-fraction-of-us-prices/"
],
[
"subject",
"Novo Nordisk’s Wegovy launches in China, offering obesity drug at a fraction of US prices"
],
[
"published_at",
"1732207083"
],
[
"image",
"https://media2.salon.com/2024/05/victoza_and_wegovy_boxes_2149254501.jpg"
],
[
"p",
"dd19d183e3f1a03d4a5119625c50db540b028ae0a098c96e4c5316df3ef5a11d",
"wss://articles.layer3.news"
],
[
"imeta",
"url https://media2.salon.com/2024/05/victoza_and_wegovy_boxes_2149254501.jpg"
],
[
"t",
"liberal:perspective"
],
[
"summary",
"Novo Nordisk has launched its popular obesity drug Wegovy in China, the world's second-largest pharmaceuticals market, where over 180 million people live with obesity. The drug will be available at a fraction of the US price, but patients will have to pay out of pocket as it is not yet covered by national healthcare insurance. Wegovy is the company's third-year-old drug that is now available in the US and 15 other countries."
]
],
"content": "nostr:nprofile1qyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqm5varqlr7xsr6jj3r939c5xm2s9s9zhq5zvvjmjv2vtd70h45ywsecrkcl\nhttps://media2.salon.com/2024/05/victoza_and_wegovy_boxes_2149254501.jpg\nThe medication is currently available in 16 other countries\nhttps://www.salon.com/2024/11/21/novo-nordisks-wegovy-launches-in-china-offering-obesity-at-a-fraction-of-us-prices/",
"sig": "17feee8abd75e5de8533d85d42ab09f7e6a2c25d7372d01a47106a2f0335e149dddb7011d537877d83307dc8d621dfe199e3757e25a00ae932ac16b1316543e1"
}
